{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:16:48Z","timestamp":1773148608915,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"crossref","award":["KSCX2-YW-R-092"],"award-info":[{"award-number":["KSCX2-YW-R-092"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Laboratory of Animal Models and Human Disease Mechanism of CAS and Yunnan Province"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jneuroim.2012.04.003","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T09:36:00Z","timestamp":1335519360000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Exposure to morphine affects the expression of endocannabinoid receptors and immune functions"],"prefix":"10.1016","volume":"247","author":[{"given":"Qing-Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.04.003_bb0005","first-page":"210","article-title":"T-helper 1 and 2 plasma cytokine assay in chronic opioid addicts","volume":"18","author":"Azarang","year":"2007","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0625.2010.01158.x","article-title":"Endogenous \u03bc-opioid peptides modulate immune response towards malignant melanoma","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0015","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4049\/jimmunol.0802763","article-title":"Mechanisms of opioid-mediated inhibition of human T cell receptor signaling","volume":"183","author":"B\u00f6rner","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2008.03.004","article-title":"Chronic exposure of human macrophages in vitro to morphine and methadone induces a putative tolerant\/dependent state","volume":"196","author":"Delgado-V\u00e9lez","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0025","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hipo.20216","article-title":"Morphine conditioned place preference depends on glucocorticoid receptors in both hippocampus and nucleus accumbens","volume":"16","author":"Dong","year":"2006","journal-title":"Hippocampus"},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0030","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1073\/pnas.95.11.6326","article-title":"Abolition of morphine-immunosuppression in mice lacking the \u03bc-opioid receptor gene","volume":"95","author":"Gaveriaux-Ruff","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.febslet.2004.10.064","article-title":"Echinacea alkylamides modulate TNF-\u03b1 gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways","volume":"577","author":"Gertsch","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0040","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1523\/JNEUROSCI.0170-06.2006","article-title":"Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced long-term depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration","volume":"26","author":"Grueter","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1189\/jlb.0710402","article-title":"Opioid-induced chemokine expression requires NF-\u03baB activity: the role of PKC\u03b6","volume":"89","author":"Happel","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0050","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.4049\/jimmunol.175.4.2655","article-title":"Morphine withdrawal contributes to Th cell differentiation by biasing cells toward the Th2 lineage","volume":"175","author":"Kelschenbach","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11481-005-9007-x","article-title":"Cannabinoid-induced immune suppression and modulation of antigen-presenting cells","volume":"1","author":"Klein","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1189\/jlb.0303101","article-title":"The cannabinoid system and immune modulation","volume":"74","author":"Klein","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0065","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2174\/138945010790980312","article-title":"Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors","volume":"11","author":"L\u00f3pez-Moreno","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2010.10.017","article-title":"Morphine decreases early peritoneal innate immunity responses in Swiss-Webster and C57BL6\/J mice through the inhibition of mast cell TNF-\u03b1 release","volume":"232","author":"Madera-Salcedo","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0075","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0080","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood-2002-01-0098","article-title":"Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease","volume":"100","author":"McKallip","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1533-2500.2009.00259.x","article-title":"Citalopram enhances B cell numbers in a murine model of morphine-induced immunosuppression","volume":"9","author":"Nguyen","year":"2009","journal-title":"Pain Pract."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/0-306-47611-8_27","article-title":"CB1 and CB2 receptor mRNA expression in human peripheral blood mononuclear cells (PBMC) from various donor types","volume":"493","author":"Nong","year":"2001","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0095","doi-asserted-by":"crossref","first-page":"e1640","DOI":"10.1371\/journal.pone.0001640","article-title":"Brain neuronal CB2 cannabionoid receptors in drug abuse and depression: from mice to human subjects","volume":"3","author":"Onaivi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1196\/annals.1432.036","article-title":"Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression","volume":"1139","author":"Onaivi","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/138945010790980367","article-title":"Cellular mechanisms underlying the interaction between cannabinoid and opioid system","volume":"11","author":"Parolaro","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-3565(25)21481-1","article-title":"Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse","volume":"230","author":"Porreca","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0115","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuropharm.2006.05.019","article-title":"Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core","volume":"51","author":"Schoffelmeer","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0120","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1172\/JCI42551","article-title":"CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity","volume":"120","author":"Tam","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0125","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.imbio.2009.12.005","article-title":"Cannabinoids and the immune system: an overview","volume":"215","author":"Tanasescu","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0130","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/sj.npp.1300117","article-title":"Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain","volume":"28","author":"Vigan\u00f2","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0135","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pbb.2005.01.021","article-title":"Molecular and cellular basis of cannabinoid and opioid interactions","volume":"81","author":"Vigan\u00f2","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0140","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1189\/jlb.71.5.782","article-title":"The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the \u03bc-opioid receptor","volume":"71","author":"Wang","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0145","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence","volume":"81","author":"Williams","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jneuroim.2012.04.003_bb0150","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/FBP.0b013e3283123c83","article-title":"Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system","volume":"19","author":"Zarrindast","year":"2008","journal-title":"Behav. Pharmacol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812001038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812001038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:18:26Z","timestamp":1759047506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812001038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0165572812001038"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.04.003","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure to morphine affects the expression of endocannabinoid receptors and immune functions","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}